These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 27258897)

  • 21. SAR and QSAR modeling of endocrine disruptors.
    Devillers J; Marchand-Geneste N; Carpy A; Porcher JM
    SAR QSAR Environ Res; 2006 Aug; 17(4):393-412. PubMed ID: 16920661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery.
    Sakkiah S; Ng HW; Tong W; Hong H
    Expert Opin Ther Targets; 2016 Oct; 20(10):1267-82. PubMed ID: 27195510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear receptor profiling of bisphenol-A and its halogenated analogues.
    Delfosse V; Grimaldi M; le Maire A; Bourguet W; Balaguer P
    Vitam Horm; 2014; 94():229-51. PubMed ID: 24388193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise.
    Brown TR
    Endocrinology; 2004 Dec; 145(12):5417-9. PubMed ID: 15545403
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of androgen receptor antagonists: In vitro investigation and classification methodology for flavonoid.
    Wu Y; Doering JA; Ma Z; Tang S; Liu H; Zhang X; Wang X; Yu H
    Chemosphere; 2016 Sep; 158():72-9. PubMed ID: 27258897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus.
    Sakkiah S; Wang T; Zou W; Wang Y; Pan B; Tong W; Hong H
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the computational development of androgen receptor antagonists.
    Hu X; Chai X; Wang X; Duan M; Pang J; Fu W; Li D; Hou T
    Drug Discov Today; 2020 Aug; 25(8):1453-1461. PubMed ID: 32439609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity.
    Soto AM; Maffini MV; Schaeberle CM; Sonnenschein C
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):15-33. PubMed ID: 16522517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiandrogens as environmental endocrine disruptors.
    Kelce WR; Gray LE; Wilson EM
    Reprod Fertil Dev; 1998; 10(1):105-11. PubMed ID: 9727600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico methods in the discovery of endocrine disrupting chemicals.
    Vuorinen A; Odermatt A; Schuster D
    J Steroid Biochem Mol Biol; 2013 Sep; 137():18-26. PubMed ID: 23688835
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.